• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.69% Nasdaq Down1.07%

    Supernus Pharmaceuticals, Inc. (SUPN)

    -NGM
    18.15 Up 0.35(1.97%) 4:00PM EDT
    |After Hours : 18.15 Down 0.00 (0.02%) 4:41PM EDT
    Add to Portfolio
    Cash FlowGet Cash Flow for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Net Income 19,871   (92,273) (46,284)
    Operating Activities, Cash Flows Provided By or Used In
    Depreciation3,018  3,775  1,201  
    Adjustments To Net Income2,345  24,874  1,096  
    Changes In Accounts Receivables(12,216)(5,043)(11)
    Changes In Liabilities2,148  17,607  (869)
    Changes In Inventories(6,289)(6,000)(1,152)
    Changes In Other Operating Activities(1,144)(889)(1,180)
    Total Cash Flow From Operating Activities 7,733   (57,949) (47,199)
    Investing Activities, Cash Flows Provided By or Used In
    Capital Expenditures(593)(1,646)(753)
    Investments211  (9,761)(48,206)
    Other Cash flows from Investing Activities(4,505)(705) -  
    Total Cash Flows From Investing Activities (4,887) (12,112) (48,959)
    Financing Activities, Cash Flows Provided By or Used In
    Dividends Paid -   -   -  
    Sale Purchase of Stock570  710  100,735  
    Net Borrowings -  65,656  (6,775)
    Other Cash Flows from Financing Activities -   -   -  
    Total Cash Flows From Financing Activities 570   62,739   87,916  
    Effect Of Exchange Rate Changes -   -   -  
    Change In Cash and Cash Equivalents 3,416   (7,322) (8,242)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.